Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3732724010 | Product containing only hydroflumethiazide and spironolactone (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3732725011 | Hydroflumethiazide and spironolactone only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
2860171000001111 | Co-flumactone (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
2860181000001113 | Co-flumactone | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Co-flumactone | Is a | Product containing hydroflumethiazide and spironolactone | true | Inferred relationship | Existential restriction modifier | ||
Co-flumactone | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Co-flumactone | Has active ingredient | Spironolactone | true | Inferred relationship | Existential restriction modifier | 1 | |
Co-flumactone | Has active ingredient | Hydroflumethiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
Co-flumactone | Plays role | Potassium-sparing diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Co-flumactone | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Is a | True | Co-flumactone | Inferred relationship | Existential restriction modifier | |
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet | Is a | True | Co-flumactone | Inferred relationship | Existential restriction modifier | |
Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | True | Co-flumactone | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets